A global research priority agenda to advance public health responses to fatty liver disease
- Autores
- Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; Noureddin, Mazen; Alazawi, William; Alkhouri, Naim; Alqahtani, Saleh A.; Arrese, Marco; Bataller, Ramon; Berg, Thomas; Brennan, Paul N.; Burra, Patrizia; Castro Narro, Graciela E.; Cortez Pinto, Helena; Cusi, Kenneth; Dedes, Nikos; Duseja, Ajay; Francque, Sven M.; Hagström, Hannes; Huang, Terry T. K.; Wajcman, Dana Ivancovsky; Valenti, Luca; Zelber-Sagi, Shira; Schattenberg, Jörn M.; Wong, Vincent Wai-Sun; Younossi, Zobair M.; Zheng, Kenneth I.; Sookoian, Silvia Cristina
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.
Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; España
Fil: Mark, Henry E.. European Association for the Study of the Liver; Suiza
Fil: Allen, Alina M.. Mayo Clinic; Estados Unidos
Fil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; Canadá
Fil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; Francia
Fil: Noureddin, Mazen. Houston Methodist Hospital; Estados Unidos
Fil: Alazawi, William. Queen Mary University of London; Estados Unidos
Fil: Alkhouri, Naim. Arizona Liver Health; Estados Unidos
Fil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia Saudita
Fil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; Chile
Fil: Bataller, Ramon. Universidad de Barcelona; España
Fil: Berg, Thomas. Universitat Leipzig; Alemania
Fil: Brennan, Paul N.. University of Dundee; Reino Unido
Fil: Burra, Patrizia. Università di Padova; Italia
Fil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; Chile
Fil: Cortez Pinto, Helena. Universidade Nova de Lisboa; Portugal
Fil: Cusi, Kenneth. University of Florida; Estados Unidos
Fil: Dedes, Nikos. Greek Patients Association; Grecia
Fil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; India
Fil: Francque, Sven M.. Universiteit Antwerp; Bélgica
Fil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia
Fil: Huang, Terry T. K.. City University of New York; Estados Unidos
Fil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; España
Fil: Valenti, Luca. Università degli Studi di Milano; Italia
Fil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; Israel
Fil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong
Fil: Younossi, Zobair M.. Universiteit Antwerp; Bélgica
Fil: Zheng, Kenneth I.. Universiteit Antwerp; Bélgica
Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; Argentina - Materia
-
DELPHI METHOD
GLOBAL HEALTH
NAFLD/NASH
NON-COMMUNICABLE DISEASE (NCD)
STEATOTIC LIVER DISEASE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/240520
Ver los metadatos del registro completo
id |
CONICETDig_31b1d687f39b0649b5f4312ace3a2f7f |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/240520 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
A global research priority agenda to advance public health responses to fatty liver diseaseLazarus, Jeffrey V.Mark, Henry E.Allen, Alina M.Arab, Juan PabloCarrieri, PatriziaNoureddin, MazenAlazawi, WilliamAlkhouri, NaimAlqahtani, Saleh A.Arrese, MarcoBataller, RamonBerg, ThomasBrennan, Paul N.Burra, PatriziaCastro Narro, Graciela E.Cortez Pinto, HelenaCusi, KennethDedes, NikosDuseja, AjayFrancque, Sven M.Hagström, HannesHuang, Terry T. K.Wajcman, Dana IvancovskyValenti, LucaZelber-Sagi, ShiraSchattenberg, Jörn M.Wong, Vincent Wai-SunYounossi, Zobair M.Zheng, Kenneth I.Sookoian, Silvia CristinaDELPHI METHODGLOBAL HEALTHNAFLD/NASHNON-COMMUNICABLE DISEASE (NCD)STEATOTIC LIVER DISEASEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat.Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; EspañaFil: Mark, Henry E.. European Association for the Study of the Liver; SuizaFil: Allen, Alina M.. Mayo Clinic; Estados UnidosFil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; CanadáFil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; FranciaFil: Noureddin, Mazen. Houston Methodist Hospital; Estados UnidosFil: Alazawi, William. Queen Mary University of London; Estados UnidosFil: Alkhouri, Naim. Arizona Liver Health; Estados UnidosFil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia SauditaFil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; ChileFil: Bataller, Ramon. Universidad de Barcelona; EspañaFil: Berg, Thomas. Universitat Leipzig; AlemaniaFil: Brennan, Paul N.. University of Dundee; Reino UnidoFil: Burra, Patrizia. Università di Padova; ItaliaFil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; ChileFil: Cortez Pinto, Helena. Universidade Nova de Lisboa; PortugalFil: Cusi, Kenneth. University of Florida; Estados UnidosFil: Dedes, Nikos. Greek Patients Association; GreciaFil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; IndiaFil: Francque, Sven M.. Universiteit Antwerp; BélgicaFil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; SueciaFil: Huang, Terry T. K.. City University of New York; Estados UnidosFil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; EspañaFil: Valenti, Luca. Università degli Studi di Milano; ItaliaFil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; IsraelFil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; AlemaniaFil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong KongFil: Younossi, Zobair M.. Universiteit Antwerp; BélgicaFil: Zheng, Kenneth I.. Universiteit Antwerp; BélgicaFil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; ArgentinaElsevier Science2023-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/240520Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-6340168-8278CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2023.04.035info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0168827823003239info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:18:25Zoai:ri.conicet.gov.ar:11336/240520instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:18:25.747CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
A global research priority agenda to advance public health responses to fatty liver disease |
title |
A global research priority agenda to advance public health responses to fatty liver disease |
spellingShingle |
A global research priority agenda to advance public health responses to fatty liver disease Lazarus, Jeffrey V. DELPHI METHOD GLOBAL HEALTH NAFLD/NASH NON-COMMUNICABLE DISEASE (NCD) STEATOTIC LIVER DISEASE |
title_short |
A global research priority agenda to advance public health responses to fatty liver disease |
title_full |
A global research priority agenda to advance public health responses to fatty liver disease |
title_fullStr |
A global research priority agenda to advance public health responses to fatty liver disease |
title_full_unstemmed |
A global research priority agenda to advance public health responses to fatty liver disease |
title_sort |
A global research priority agenda to advance public health responses to fatty liver disease |
dc.creator.none.fl_str_mv |
Lazarus, Jeffrey V. Mark, Henry E. Allen, Alina M. Arab, Juan Pablo Carrieri, Patrizia Noureddin, Mazen Alazawi, William Alkhouri, Naim Alqahtani, Saleh A. Arrese, Marco Bataller, Ramon Berg, Thomas Brennan, Paul N. Burra, Patrizia Castro Narro, Graciela E. Cortez Pinto, Helena Cusi, Kenneth Dedes, Nikos Duseja, Ajay Francque, Sven M. Hagström, Hannes Huang, Terry T. K. Wajcman, Dana Ivancovsky Valenti, Luca Zelber-Sagi, Shira Schattenberg, Jörn M. Wong, Vincent Wai-Sun Younossi, Zobair M. Zheng, Kenneth I. Sookoian, Silvia Cristina |
author |
Lazarus, Jeffrey V. |
author_facet |
Lazarus, Jeffrey V. Mark, Henry E. Allen, Alina M. Arab, Juan Pablo Carrieri, Patrizia Noureddin, Mazen Alazawi, William Alkhouri, Naim Alqahtani, Saleh A. Arrese, Marco Bataller, Ramon Berg, Thomas Brennan, Paul N. Burra, Patrizia Castro Narro, Graciela E. Cortez Pinto, Helena Cusi, Kenneth Dedes, Nikos Duseja, Ajay Francque, Sven M. Hagström, Hannes Huang, Terry T. K. Wajcman, Dana Ivancovsky Valenti, Luca Zelber-Sagi, Shira Schattenberg, Jörn M. Wong, Vincent Wai-Sun Younossi, Zobair M. Zheng, Kenneth I. Sookoian, Silvia Cristina |
author_role |
author |
author2 |
Mark, Henry E. Allen, Alina M. Arab, Juan Pablo Carrieri, Patrizia Noureddin, Mazen Alazawi, William Alkhouri, Naim Alqahtani, Saleh A. Arrese, Marco Bataller, Ramon Berg, Thomas Brennan, Paul N. Burra, Patrizia Castro Narro, Graciela E. Cortez Pinto, Helena Cusi, Kenneth Dedes, Nikos Duseja, Ajay Francque, Sven M. Hagström, Hannes Huang, Terry T. K. Wajcman, Dana Ivancovsky Valenti, Luca Zelber-Sagi, Shira Schattenberg, Jörn M. Wong, Vincent Wai-Sun Younossi, Zobair M. Zheng, Kenneth I. Sookoian, Silvia Cristina |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
DELPHI METHOD GLOBAL HEALTH NAFLD/NASH NON-COMMUNICABLE DISEASE (NCD) STEATOTIC LIVER DISEASE |
topic |
DELPHI METHOD GLOBAL HEALTH NAFLD/NASH NON-COMMUNICABLE DISEASE (NCD) STEATOTIC LIVER DISEASE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Fil: Lazarus, Jeffrey V.. City University of New York; Estados Unidos. Universidad de Barcelona; España Fil: Mark, Henry E.. European Association for the Study of the Liver; Suiza Fil: Allen, Alina M.. Mayo Clinic; Estados Unidos Fil: Arab, Juan Pablo. Pontificia Universidad Católica de Chile; Chile. Western University; Canadá Fil: Carrieri, Patrizia. Inserm; Francia. Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale; Francia Fil: Noureddin, Mazen. Houston Methodist Hospital; Estados Unidos Fil: Alazawi, William. Queen Mary University of London; Estados Unidos Fil: Alkhouri, Naim. Arizona Liver Health; Estados Unidos Fil: Alqahtani, Saleh A.. King Faisal Specialist Hospital And Research Centre; Arabia Saudita Fil: Arrese, Marco. Universidad Católica de Chile; Chile. Pontificia Universidad Católica de Chile; Chile Fil: Bataller, Ramon. Universidad de Barcelona; España Fil: Berg, Thomas. Universitat Leipzig; Alemania Fil: Brennan, Paul N.. University of Dundee; Reino Unido Fil: Burra, Patrizia. Università di Padova; Italia Fil: Castro Narro, Graciela E.. Instituto Nacional de la Nutrición Salvador Zubiran; México. Fundacion Clinica Medica Sur; México. Asociación Latinoamericana Para El Estudio del Hígado; Chile Fil: Cortez Pinto, Helena. Universidade Nova de Lisboa; Portugal Fil: Cusi, Kenneth. University of Florida; Estados Unidos Fil: Dedes, Nikos. Greek Patients Association; Grecia Fil: Duseja, Ajay. Postgraduate Institute of Medical Education and Research; India Fil: Francque, Sven M.. Universiteit Antwerp; Bélgica Fil: Hagström, Hannes. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia Fil: Huang, Terry T. K.. City University of New York; Estados Unidos Fil: Wajcman, Dana Ivancovsky. Universidad de Barcelona; España Fil: Valenti, Luca. Università degli Studi di Milano; Italia Fil: Zelber-Sagi, Shira. University Of Haifa; Israel. Universitat Tel Aviv; Israel Fil: Schattenberg, Jörn M.. Johannes Gutenberg Universitat Mainz; Alemania Fil: Wong, Vincent Wai-Sun. Chinese University Of Hong Kong; Hong Kong Fil: Younossi, Zobair M.. Universiteit Antwerp; Bélgica Fil: Zheng, Kenneth I.. Universiteit Antwerp; Bélgica Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina. Universidad Abierta Interamericana; Argentina |
description |
Background & aims: An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods: Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a threeday in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results: The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a supermajority of agreement (>66.7% ‘agree’), 13 priorities had <80% ‘agree’, with greater reliance on ‘somewhat agree’ to achieve >90% combined agreement. Conclusions: Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/240520 Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-634 0168-8278 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/240520 |
identifier_str_mv |
Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M.; Arab, Juan Pablo; Carrieri, Patrizia; et al.; A global research priority agenda to advance public health responses to fatty liver disease; Elsevier Science; Journal of Hepatology; 79; 3; 9-2023; 618-634 0168-8278 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2023.04.035 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0168827823003239 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Science |
publisher.none.fl_str_mv |
Elsevier Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614145991770112 |
score |
13.070432 |